Stages of Kidney Cancer
Definition of Staging
A staging system lets doctors know if the cancer has spread and to what extent. Staging describes the extent or severity of cancer based on the size of the original (primary) tumor and the extent to which it has spread in the body. There are several staging systems for kidney cancer but the most widely used system in the United States is called the TNM System. It is also known as the Staging System of the American Joint Committee on Cancer (AJCC).1
General Information on Staging
Staging is based on knowledge of how cancer develops. Cancer cells divide and grow to form a mass of tissue called a growth or tumor. As a tumor grows, it can spread to nearby organs and tissues. Cancer cells may also break away from the tumor and enter the bloodstream or lymphatic system. By moving through the bloodstream or lymphatic system, cancer can spread from the primary site to form new tumors in other organs. The spread of cancer is called metastasis.
Purpose of Staging
Staging helps with the cancer diagnosis and treatment process in important ways, including:
- Helping the doctors to effectively plan a patient's treatment
- Estimating the patient's prognosis (likely outcome or course of the disease)
- Helping to identify clinical trials that may be suitable for a particular patient.1
Staging helps researchers and health care providers exchange information about patients and provide a common language for diagnosis, treatment and clinical trials.
Staging Kidney Cancer
The AJCC staging system includes the primary kidney tumor (T stage), the lymph nodes near the kidney (N stage) and the presence or absence of metastases (M stage) to determine if the cancer has spread. In kidney cancer, the lymph nodes near the kidney are referred to as regional lymph nodes. Clinical stage is based on radiographic imaging before surgery. Pathologic stage is based on the analysis of the tissue that has been surgically removed.
The tumor is confined to the kidney. There is no spread to lymph nodes or distant organs.
The tumor has invaded the fat around the kidney or the adrenal gland above the kidney. There is no spread to lymph nodes or other organs.
There are several combinations of T and N categories that are included in this stage. These include tumors of any size, with spread into the lymph nodes adjacent to the kidney or into the large veins leading from the kidney to the heart (venous tumor thrombus). This stage does not include tumors that invade other nearby organs or more distant organs.
There are several combinations of T, N, and M categories included in this stage. This stage includes any cancers that have invaded into nearby organs such as the colon (large bowel) or the abdominal wall as well as more distant organs in the body.
Primary Tumor (T):
Primary tumor cannot be assessed
No evidence of primary tumor
Tumor 7.0 cm or less, confined to the kidney
Tumor 4.0 cm or less, confined to the kidney
Tumor 4.0-7.0 cm, confined to the kidney
Tumor greater than 7.0 cm, limited to kidney
Tumor extends into major veins/adrenal/tissue; not beyond Gerota's fascia
Tumor invades adrenal/perinephric fat
Tumor extends into renal vein(s) or vena cava below diaphragm
Tumor extends into vena cava above diaphragm
Tumor invades beyond Gerota's fascia, into adjacent organ systems.
N - Regional Lymph Nodes
Regional nodes cannot be assessed
No regional lymph node metastasis
Metastasis in a single regional lymph node
Metastasis in more than one regional lymph node
M - Distant Metastasis
Distant metastasis cannot be assessed
No distant metastasis
- "About Kidney Cancer", Kidney Cancer Association, www.kidneycancer.org , URL: http://www.kidneycancer.org/knowledge/learn/about-kidney-cancer
PN 1002326 Rev A 04/2013
Serious complications may occur in any surgery, including da Vinci® Surgery, up to and including death. Examples of serious or life-threatening complications, which may require prolonged and/or unexpected hospitalization and/or reoperation, include but are not limited to, one or more of the following: injury to tissues/organs, bleeding, infection and internal scarring that can cause long-lasting dysfunction/pain. Risks of surgery also include the potential for equipment failure and/or human error. Individual surgical results may vary.
Risks specific to minimally invasive surgery, including da Vinci ® Surgery, include but are not limited to, one or more of the following: temporary pain/nerve injury associated with positioning; temporary pain/discomfort from the use of air or gas in the procedure; a longer operation and time under anesthesia and conversion to another surgical technique. If your doctor needs to convert the surgery to another surgical technique, this could result in a longer operative time, additional time under anesthesia, additional or larger incisions and/or increased complications.
Patients who are not candidates for non-robotic minimally invasive surgery are also not candidates for da Vinci® Surgery. Patients should talk to their doctor to decide if da Vinci ® Surgery is right for them. Patients and doctors should review all available information on non-surgical and surgical options in order to make an informed decision. For Important Safety Information, including surgical risks, indications, and considerations and contraindications for use, please also refer to www.davincisurgery.com/safety and www.intuitivesurgical.com/safety. Unless otherwise noted, all people depicted are models.
© 2014 Intuitive Surgical. All rights reserved. All product names are trademarks or registered trademarks of their respective holders.
Content provided by Intuitive Surgical.